Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3, Multi-centre, Prospective, Open, Randomized, in Two Parallel Groups Study to Evaluate Efficacy and Tolerance of Patient's Learning in Self-taking of Prescribed Asthma Maintenance Treatments and Provided by a Robot Named JOE.

NCT04942639 is registered in ClinicalTrials.gov with Ludocare SAS as lead sponsor.

NCT NCT04942639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04942639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3, Multi-centre, Prospective, Open, Randomized, in Two Parallel Groups Study to Evaluate Efficacy and Tolerance of Patient's Learning in Self-taking of Prescribed Asthma Maintenance Treatments and Provided by a Robot Named JOE.
Lead sponsor
Ludocare SAS
Phase
Not applicable
Overall status
Unknown status
Start date
October 18, 2022
Completion date
December 31, 2024
Enrollment
213 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

asthma in children